These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27272042)

  • 1. Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo).
    Bird MF; Cerlesi MC; Brown M; Malfacini D; Vezzi V; Molinari P; Micheli L; Di Cesare Mannelli L; Ghelardini C; Guerrini R; Calò G; Lambert DG
    PLoS One; 2016; 11(6):e0156897. PubMed ID: 27272042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligands.
    Bird MF; McDonald J; Horley B; O'Doherty JP; Fraser B; Gibson CL; Guerrini R; Caló G; Lambert DG
    PLoS One; 2022; 17(1):e0260880. PubMed ID: 35061679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
    Molinari S; Camarda V; Rizzi A; Marzola G; Salvadori S; Marzola E; Molinari P; McDonald J; Ko MC; Lambert DG; Calo' G; Guerrini R
    Br J Pharmacol; 2013 Jan; 168(1):151-62. PubMed ID: 22827708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of [Cys(ATTO 488)8]Dermorphin-NH2 as a novel tool for the study of μ-opioid peptide receptors.
    Giakomidi D; Bird MF; McDonald J; Marzola E; Guerrini R; Chanoch S; Sabu N; Horley B; Calo G; Lambert DG
    PLoS One; 2021; 16(4):e0250011. PubMed ID: 33891604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
    J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol.
    Bojnik E; Babos F; Fischetti C; Magyar A; Camarda V; Borsodi A; Bajusz S; Calo' G; Benyhe S
    Brain Res Bull; 2010 Mar; 81(4-5):477-83. PubMed ID: 19800951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors.
    Pacifico S; Albanese V; Illuminati D; Fantinati A; Marzola E; Ferrari F; Neto JA; Sturaro C; Ruzza C; Calò G; Preti D; Guerrini R
    Bioconjug Chem; 2019 Sep; 30(9):2444-2451. PubMed ID: 31461266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
    Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of the non-peptide nociceptin receptor agonist, Ro64-6198 in Chinese hamster ovary cells expressing recombinant human nociceptin receptors.
    Hashiba E; Lambert DG; Jenck F; Wichmann J; Smith G
    Life Sci; 2002 Mar; 70(15):1719-25. PubMed ID: 12002517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations.
    Ferrari F; Cerlesi MC; Malfacini D; Asth L; Gavioli EC; Journigan BV; Kamakolanu UG; Meyer ME; Yasuda D; Polgar WE; Rizzi A; Guerrini R; Ruzza C; Zaveri NT; Calo G
    Eur J Pharmacol; 2016 Dec; 793():1-13. PubMed ID: 27780725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
    Spagnolo B; Carrà G; Fantin M; Fischetti C; Hebbes C; McDonald J; Barnes TA; Rizzi A; Trapella C; Fanton G; Morari M; Lambert DG; Regoli D; Calò G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):961-7. PubMed ID: 17329552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.
    Thompson AA; Liu W; Chun E; Katritch V; Wu H; Vardy E; Huang XP; Trapella C; Guerrini R; Calo G; Roth BL; Cherezov V; Stevens RC
    Nature; 2012 May; 485(7398):395-9. PubMed ID: 22596163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells.
    Wright KE; McDonald J; Barnes TA; Rowbotham DJ; Guerrini R; Calo' G; Lambert DG
    Neurosci Lett; 2003 Aug; 346(3):145-8. PubMed ID: 12853105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G; Rizzi A; Guerrini R; Barnes TA; McDonald J; Hebbes CP; Mela F; Kenigs VA; Marzola G; Rizzi D; Gavioli E; Zucchini S; Regoli D; Morari M; Salvadori S; Rowbotham DJ; Lambert DG; Kapusta DR; Calo' G
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1114-23. PubMed ID: 15509719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative study of [Tyr10]nociceptin/orphanin FQ (1-11) at NOP receptors in rat periaqueductal gray and expressed NOP receptors in HEK293 cells.
    Liao YY; Lee CW; Ho IK; Chiou LC
    Life Sci; 2012 Feb; 90(7-8):306-12. PubMed ID: 22213115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt
    Cerlesi MC; Ding H; Bird MF; Kiguchi N; Ferrari F; Malfacini D; Rizzi A; Ruzza C; Lambert DG; Ko MC; Calo G; Guerrini R
    Eur J Pharmacol; 2017 Jan; 794():115-126. PubMed ID: 27871910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Mixed NOP/Opioid Receptor Peptide Agonists.
    Pacifico S; Albanese V; Illuminati D; Marzola E; Fabbri M; Ferrari F; Holanda VAD; Sturaro C; Malfacini D; Ruzza C; Trapella C; Preti D; Lo Cascio E; Arcovito A; Della Longa S; Marangoni M; Fattori D; Nassini R; Calò G; Guerrini R
    J Med Chem; 2021 May; 64(10):6656-6669. PubMed ID: 33998786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
    Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
    Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development.
    Wtorek K; Janecka A
    Chem Biodivers; 2021 Jan; 18(1):e2000871. PubMed ID: 33351271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.